Welcome back to the end of the week wrap up where we compile and share the latest cannabis news.
As cannabis entrepreneurs and operators, we can all agree that the best way to learn about the industry is to actively get involved. Whether it’s in distribution, GMP manufacturing or thought leadership, implementation creates new neural pathways.
Each week, even if it’s 1%, we work to grow our businesses by analysing and implementing what we learn from the articles shared. The lessons help us come up with improved ideas and solutions.
You see, this game is beyond our home base of Australia.?
Cannabis is worldwide and there are various factors to consider when making key business decisions. To discover these factors one must step out of their comfort zone.
With that said, here are some of the top articles we discovered this week on everything cannabis:
- Net revenue for the quarter ended Sept. 30 was CA$49.3 million, down 2% from the previous quarter and down 18% from the same quarter a year before.
- The Alberta-based company reported a CA$618.7 million loss in its previous quarter, primarily due to large impairment charges.
- Aurora, which has refocused its business on medical marijuana, reported CA$31.6 million in medical cannabis net revenue for the quarter.
- CA$8.2 million of medical cannabis sold in countries other than Canada.
Key Takeaway: Despite experiencing quarterly losses, Aurora continues to harp on the emergence and growth of medicinal cannabis
- The health minister of Germany’s largest state is asking a key European Union official to block Germany’s plan to regulate recreational marijuana production and sales.
- In October, the German government published key details of its plan to legalize and regulate recreational cannabis
- Germany’s blueprint of the law is being sent to the European Commission, the EU’s executive branch, for approval to ensure it is compatible with EU and global drug laws.
- Germany’s government said the legislative process, including actually drafting a law, will continue only if the plan is approved by the EU
Key Takeaway: Cannabis reform in Germany and other European countries must be approved by the European Commission before it can be approved by its lawmakers. Therefore, change and reform can take up to a decade, so think big and long-term.
- As the cannabis industry evolves from growth to maturity, it’s no surprise the market is experiencing one of the most common developments – consolidation.
- At the highly fragmented lower end, with some markets facing profit and regulatory headwinds, consolidation is driving efforts to gain market share, larger customer bases and access to attractive markets.
- Applying the skills of entrepreneurship that drove early-stage success, evolution to competency entrepreneur (or competency predator, if you prefer) can help mitigate the unpredictable nature of consolidation.
Key Takeaway: During an industry consolidation or shake-out, many companies are acquired, merge or fail. Organisations with strong foundations and focus on improving quality, processes, and systems will eventually win.
- Using a bioreactor, a company in Israel cloned hemp cells to culture them into a powdery biomass that contains all of cannabis’s active compounds and can be dialed up to 12 times the potency.
- Cannabis plants are grown mostly just for the flower and contain the critical trichomes which are the source of cannabinoids, terpenes and flavonoids.?
- BioHarvest’s technology can grow in just three weeks—while regular cannabis takes 14 to 23 weeks. Their tech can also significantly increase the levels of active ingredients, as a percent of the weight, versus what is found normally in the plant.
Key Takeaway: The way we think and approach cannabis production is going to change drastically as technology developments further.
- The Amsterdam Cannabis Expo, due to be hosted between November 24 and 26, 2022, is reportedly not taking place at all, leaving a number of would-be exhibitors scrambling to recover their lost cash.
- The three-day event was advertised as including a ‘prestigious awards show’ and a full agenda of speakers discussing ‘the latest trends’, and as offering exhibitors ‘the ideal opportunity to showcase your brand to the industry’.?
- Upon closer inspection, the warning signs were apparent. Not only did the company fail to publish any information on its agenda up until its website was taken down, just two weeks from the apparent launch of the event, but its anonymous organisers were unable to answer any questions posed by would-be exhibitors.?
Key Takeaway: Do our due diligence and vet who we do business with! Those who play the long game will always win over those seeking short-term gains by taking advantage of others.
Let us know what you think and how you're implementing the information shared each week.
Disclaimer: All articles shared are credited to its rightful owners. Information shared on this page is for educational purposes only. We are not here to promote the use of cannabis. If you do intend to consume cannabis, we advise you to speak to your local general practitioner for more information and guidance.
Director, Owner & Co-Founder at MOTHERPLANT.
2 年I am shocked the Amsterdam Expo was a scam!!! Crazy.